: Bacterial resistance to antimicrobial agents has increased in recent years and now represents a significant threat to successful antibiotic therapy. One example of this phenomenon is the development of resistance to B-Iactam antibiotics. B-lactam antibiotics, such as the penicillins and cephalosporins, are among the most frequently used antimicrobial agents. The most common mechanism of resistance to B-lactam antibiotics is the production of B-lactamases, which cleave the antibiotic, rendering it harmless to bacteria. Based on primary sequence homology, B-lactamases have been grouped into four classes. Classes A, C and D are active-site serine enzymes that catalyze, via a serine-bound acyl-enzyme intermediate, the hydrolysis of the B-Iactam antibiotic. Class B enzymes require zinc for activity and catalysis does not proceed via a covalent intermediate. Because of the diverse range of substrate specificities of these enzymes, virtually all B-lactam antibiotics are susceptible to hydrolysis. Clearly, the design of new antibiotics that escape hydrolysis by the growing collection of B-lactamase activities will be a challenge. It will be necessary to understand the catalytic mechanism and basis for substrate specificity of each class of B-lactamase. The goal of this work is understand how the amino acid sequence determines the structure, catalysis, and substrate specificity of the IMP-I B-lactamase of class B and the P99 class C B-lactamase. This will be achieved by randomizing amino acid positions in the active-site pocket of each enzyme to sample all possible amino acid substitutions. All of the random substitutions will then be screened to identify those substitutions that alter the substrate specificity of the enzyme. Enzymes containing substitutions that alter substrate specificity will be purified and characterized biochemically. The sets of random substitutions will also be screened using phage display methodology to identify residues critical for catalysis. A further goal of this proposal is to use the detailed knowledge of the interface between B-lactamase inhibitory protein (BLIP) and B-lactamase, in combination with random mutagenesis and phage display, to create derivatives of BLIP that bind and inhibit B-lactamases and penicillin binding proteins. The new' BLIP derivatives will be characterized biochemically and structurally. The information gained from these studies will be useful for the rational design of new antibiotics and inhibitors.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37AI032956-13
Application #
6730521
Study Section
Bacteriology and Mycology Subcommittee 2 (BM)
Program Officer
Peters, Kent
Project Start
1992-07-01
Project End
2006-04-30
Budget Start
2004-05-01
Budget End
2005-04-30
Support Year
13
Fiscal Year
2004
Total Cost
$301,000
Indirect Cost
Name
Baylor College of Medicine
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Sun, Zhizeng; Hu, Liya; Sankaran, Banumathi et al. (2018) Differential active site requirements for NDM-1 ?-lactamase hydrolysis of carbapenem versus penicillin and cephalosporin antibiotics. Nat Commun 9:4524
Adamski, Carolyn J; Palzkill, Timothy (2017) BLIP-II Employs Differential Hotspot Residues To Bind Structurally Similar Staphylococcus aureus PBP2a and Class A ?-Lactamases. Biochemistry 56:1075-1084
Stojanoski, Vlatko; Adamski, Carolyn J; Hu, Liya et al. (2016) Removal of the Side Chain at the Active-Site Serine by a Glycine Substitution Increases the Stability of a Wide Range of Serine ?-Lactamases by Relieving Steric Strain. Biochemistry 55:2479-90
Chow, Dar-Chone; Rice, Kacie; Huang, Wanzhi et al. (2016) Engineering Specificity from Broad to Narrow: Design of a ?-Lactamase Inhibitory Protein (BLIP) Variant That Exclusively Binds and Detects KPC ?-Lactamase. ACS Infect Dis 2:969-979
Adamski, Carolyn J; Cardenas, Ana Maria; Brown, Nicholas G et al. (2015) Molecular basis for the catalytic specificity of the CTX-M extended-spectrum ?-lactamases. Biochemistry 54:447-57
Mehta, Shrenik C; Rice, Kacie; Palzkill, Timothy (2015) Natural Variants of the KPC-2 Carbapenemase have Evolved Increased Catalytic Efficiency for Ceftazidime Hydrolysis at the Cost of Enzyme Stability. PLoS Pathog 11:e1004949
Stojanoski, Vlatko; Chow, Dar-Chone; Fryszczyn, Bartlomiej et al. (2015) Structural Basis for Different Substrate Profiles of Two Closely Related Class D ?-Lactamases and Their Inhibition by Halogens. Biochemistry 54:3370-80
Stojanoski, Vlatko; Chow, Dar-Chone; Hu, Liya et al. (2015) A triple mutant in the ?-loop of TEM-1 ?-lactamase changes the substrate profile via a large conformational change and an altered general base for catalysis. J Biol Chem 290:10382-94
Abriata, Luciano A; Palzkill, Timothy; Dal Peraro, Matteo (2015) How structural and physicochemical determinants shape sequence constraints in a functional enzyme. PLoS One 10:e0118684
Long, S Wesley; Olsen, Randall J; Mehta, Shrenik C et al. (2014) PBP2a mutations causing high-level Ceftaroline resistance in clinical methicillin-resistant Staphylococcus aureus isolates. Antimicrob Agents Chemother 58:6668-74

Showing the most recent 10 out of 62 publications